Abstract
Pharmacomodulation of torasemide, a diuretic sulfonylurea, led to the discovery of two novel diuretics, a sulfonylthiourea (BM 20) and a sulfonylcyanoguanidine (BM 106). BM 27, a lipophilic sulfonylurea, exhibited neuroprotective properties associated to an anticonvulsant activity. As BM 27, two lipophilic sulfonylthioureas (BM 11 and BM 34) revealed an anticonvulsant profile similar to that of phenytoin. Finally the synthesis of torasemide derivatives led to the development of a sulfonylcyanoguanidine (BM 144) with a thromboxane A2 antagonist potency.
Original language | English |
---|---|
Pages (from-to) | 157-158 |
Number of pages | 2 |
Journal | Journal de Pharmacie de Belgique |
Volume | 52 |
Issue number | 4 |
Publication status | Published - 1 Jul 1997 |